Congress of Clinical Rheumatology April 30

Transcription

Up to 28 hours AMA PRA Category 1 CreditsTM available.
Congress of Clinical Rheumatology
April 30-May 3, 2015
Sandestin hilton and conference center • Destin FL.
dear colleagues,
It is with pleasure that I invite you to attend the 31st Congress of Clinical
Rheumatology being held Thursday, April 30 - Sunday, May 3, 2015 at the
Sandestin Hilton Hotel and Resort in Destin, Florida, on Florida’s Emerald
Coast. The Congress of Clinical Rheumatology is designed with the clinical
rheumatologist in mind. Presentations include cutting edge topics, clinical
guidelines, and evidence based medicine along with unique case studies. The
faculty changes each year and is chosen according to the desired area of
expertise and presenter’s skills. CCR 2015 is very fortunate to have faculty from
universities throughout the world, including four from Europe. In addition, the
faculty will contain four former CCR Outstanding Speaker Award winners—Iain
McInnes, Ed Keystone, Susan Manzi, and Michelle Petri. Being an Outstanding
Speaker is not an easy feat in a Rheumatology Who’s Who faculty.
Other topics to be discussed will be CTD-associated ILD and sarcoid by Kristin
Highland, M.D., who is boarded in Rheumatology and Pulmonary; an ICD-10
update by Charles King, II, MD, has just joined ACR’s Board Of Directors but
was formerly the chairman of CORC for many years and; a Saturday Banquet
with CCR and associated programs, but where there is only one meeting
talk describing The Discovery of Cortisone by Thom Rooke, MD, a Mayo
room, one fee to attend all the sessions, and one agenda. It is easy to see
Professor, who authored, The Quest for Cortisone. Other faculty members will
why many participants say they learn more at CCR than at any other meeting
discuss often-overlooked topics, such as osteoporosis and chronic pain, as well
they attend during the year. This is the perfect place to have a great time
as new and emerging issues on the horizon. Jarred Younger, PhD, formerly of
renewing old friendships, to meet the new fellows coming in for NYRIF the
the Stanford Pain Center and currently at UAB, will discuss the importance of
day before CCR, and to learn clinical rheumatology. Come and enjoy!
microglial modulation in the development of more targeted treatment strategies
in fibromyalgia whereas Iain McInnes will discuss the future prospects for RA
and PsA treatments. All in all, it should be another outstanding meeting.
CCR is the place to go to an international meeting with a world-class faculty,
where participants can earn as many as 28 AMA PRA Category 1 Credits™
Best,
David
David McLain, MD, FACP, FACR; Symposium Director, CCR; Birmingham, AL.
re g i ste r o n l i n e n o w at w w w . c c r h e um ato lo gy . c om
FACULTY
John Bilezikian, M.D.
Daniel Doleys, Ph.D.
Professor of Medicine and Pharmacology
Chief, Division of Endocrinology
Associate Chair (Education), Department of Medicine
Columbia University College of Physicians and Surgeons
New York, NY
Director, The Doleys Clinic
Author, Pain: Dynamics and Complexities
Birmingham, AL
Frank Buttgereit, M.D.
Professor of Rheumatology
Deputy Chief of the Department of Rheumatology and
Clinical Immunology
Charité - University Medicine
Berlin, Germany
Kristin Highland, M.D.
Department of Pulmonary,
Allergy & Critical Care Medicine, Respiratory Institute
(Board Certified in Rheumatology and Pulmonary Disease)
Cleveland Clinic
Cleveland, OH
3
Laura Coates, M.D., PhD
NIHR Clinical Lecturer
University of Leeds
Chapel Allerton Hospital
Leeds, UK
Edward Keystone, M.D.
Professor of Medicine, University of Toronto
Director, The Rebecca MacDonald Centre for Arthritis &
Autoimmune Disease
Director, The Division of Advanced Therapeutics in Arthritis
Mount Sinai Hospital Joseph & Wolf Lebovic Health Complex
Toronto, Ontario
John J. Cush, M.D.
Director of Clinical Rheumatology,
Baylor Research Inst Professor of Medicine & Rheumatology,
Baylor University Medical Center
Clinical Professor of Internal Medicine,
The University of Texas Southwestern Medical School
Dallas, Texas
Charles King, II, M.D.
North Mississippi Health Services,
Tupelo, MS
FACULTY
4
Susan Manzi, M.D., MPH
Chair, Department of Medicine,
Allegheny Health Network
Vice Chair and Professor Medicine
Temple University School of Medicine
Pittsburgh, PA
Lisa Sammaritano, M.D.
Associate Attending Physician, Hospital for Special Surgery
Associate Professor of Clinical Medicine,
Weill Cornell Medical College
New York, NY
Joseph Markenson, M.D.
Attending Physician, Hospital for Special Surgery
Professor of Clinical Medicine,
Weill Cornell Medical College
Attending Physician, Department of Medicine, Memorial
Sloan-Kettering Cancer Center
New York, NY
Philip Seo, M.D., M.H.S.
Assistant Professor of Medicine
Director, Fellowship Program
Division of Rheumatology
Johns Hopkins University School of Medicine
Director, The Johns Hopkins Vasculitis Center
Baltimore, MD
Iain McInnes, M.D., PhD, FRCP, FRSE, FMedSci
Professor of Experimental Medicine
Muirhead Professor of Medicine
Director Institute of Infection, Immunity and Inflammation
University of Glasgow
Glasgow, Scotland, UK
Athanasios G. Tzioufas, M.D.
Director, Department of Pathophysiology
School of Medicine
University of Athens
Athens, Greece
Thom W. Rooke, M.D.
John and Posy Krehbiel Professor of Medicine
Mayo Medical School
Rochester, MN
Author, The Quest for Cortisone
Jarred Younger, Ph.D.
Associate Professor, Department of Psychology,
Departments of Anesthesiology & Rheumatology
Dir of the Neuroinflammation, Pain and Fatigue Lab at UAB
University of Alabama at Birmingham
Birmingham, AL
THURSDAY, APRIL 30
7:00 AM Continental Breakfast, Exhibits
7:50 AM Welcome and Announcements
David A. McLain, M.D.
8:00 AM Current and Emerging Treatments of
Rheumatoid Arthritis
9:00 AM Pathogenesis and treatment of
Rheumatoid Arthritis in 2020?3
Iain McInnes, M.D., PhD
10:00 AM Break
10:15 AM Treating to Target in Psoriatic
Arthritis
Laura Coates, M.D.
11:15 AM Reducing the Cost of Biologics:
Dose Reduction, Withdrawal & Biosimilars
12:15 PM Lunch, Exhibits
1:15 PM PsA – a new future opening up?
Iain McInnes, M.D., PhD
2:15 PM Update on ANCA-associated
Vasculitis
Philip Seo, M.D., M.H.S.
3:15 PM Break
3:30 PM CTD associated Interstital Lung
Disease
4:25 PM Gout Update, a separate CME activity
Joseph Grisanti, M.D.
5:25 PM Adjourn
SUNDAY, MAY 3
6:15 AM Breakfast Workshop with Open Breakfast Buffet with Omelet Station
7:15 AM Adverse Drug Reactions and issues with
newer therapies in RA -
John J. Cush, M.D.
8:15 AM Non-malignant Chronic Pain Management
Dan Doleys, Ph.D.
agenda
FRIDAY, MAY 1
6:30 AM Continental Breakfast, Exhibits
7:30 AM Clinical Update on Sarcoidosis
8:30 AM Glucocorticoids in Rheumatology:
Clinical use, mechanisms of action
9:30 AM Break
9:45 AM Sjogren’s Syndrome: Clinical
Presentation and Outcome
10:45 AM Glucocorticoids in Rheumatology:
Adverse effects and new developments
11:45 PM Update on Therapies in SLE
including Complimentary & Alternative
Medications
Susan Manzi, M.D., M.P.H.
1:45 PM Lupus Pregnancy: Management and
Outcome
Lisa Sammaritano, M.D.
2:45 PM Sjogren’s Syndrome: Therapeutic
modalities: Current status and future prospects
3:45 PM Break
4:00 PM CCR Thieves’ Market
Alan Epstein, M.D
5:00 PM Adjourn
9:15 AM Break
9:30 AM Preventing Infections in patients on
Biologics
John J. Cush, M.D.
10:30 AM ICD-10 for Rheumatologists
Charles King, II, M.D.
11:30 AM Congress Adjourns for 2015
SEE YOU NEXT YEAR
SATURDAY, MAY 2
6:30 AM Continental Breakfast
7:30 AM Spondyloarthropathy Update, a
separate CME activity,
Alan Epstein, M.D.
8:30 AM Microglial Modulation in the Treatment
of Fibromyalgia
Jarred Younger, PhD
9:30 AM Break
9:45 AM New and Emerging Therapies in
Osteoporosis
10:45 AM Rheumatic Manifestations of
Endocrine Disease
Joseph Markenson, M.D.
11:45 AM The Year in Review: Osteoporosis
1:45 PM Lupus Update, a separate CME
activity
Michelle Petri, M.D., M.P.H.
2:45 PM OA update, a separate CME activity
John Tesser, M.D.
3:45 PM Adjourn
6:30 PM Cocktail Reception
7:00 PM Banquet
7:15 PM Welcome, prize drawings
7:30 PM CME Banquet Talk
The Discovery of Cortisone
Thom W. Rooke, M.D.
8:30 PM Adjourn
5
“The Spectrum of Gout and Hyperuricemia: Acute Attacks
to Refractory Chronic Gout”
Earn 1.0 AMA PRA Category 1 Credits™
s e pa r ate a ct i v i t y
You are invited to participate in an educational program that was created to provide
physicians, physician assistants, and rheumatology nurse practitioners with the
knowledge base, skills set, and tools needed to incorporate the “The Spectrum of
Gout and Hyperuricemia: Acute Attacks to Refractory Chronic Gout” CME educational
activity into clinical practice.
Upon completion of the program participants will be able to:
6
1Describe the pathophysiology of hyperuricemia and gout, and the mechanisms leading to an acute gout attack
2Describe advances in the understanding of the epidemiology of hyperuricemia and gout, and the relationship between hyperuricemia, risk factors, and
comorbidities
3Evaluate and select among the current and innovative treatments of hyperuricemia and gout, utilizing current data on efficacy and safety
4Use currently accepted standards of care to manage patients with hyperuricemia and gout, including:
• When managing acute attacks
• When implementing prophylaxis
• When treating chronic hyperuricemia
• When managing gout resistant to first line treatments
Joseph M. Grisanti, M.D., FACP, FACR.
Medical Director, Buffalo Rheumatology
Chief of Rheumatology, Mercy Hospital of Buffalo
Assistant Clinical Professor of Medicine, SUNY Buffalo
Orchard Park, NY
Accreditation and Educational Credit
This educational activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint providership of University Health Services
Professional Education Programs, Inc. (UHS-PEP) of Virginia Commonwealth University
Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to provide
continuing medical education for physicians. UHS-PEP designates this live activity for a maximum
of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with
the extent of their participation in the activity. This continuing education activity meets the criteria
of VCU and the Southern Association of Colleges and Schools. For each activity 0.1 CEUs will be
awarded and recorded with the University. This program is supported by an educational grant from
Crealta Pharmaceuticals, Inc.
“Diagnosis and Management of the Spondyloarthropathies
(SpA)-Impact of Treat to Target Guidelines”
participants with the knowledge base, skills set, and tools needed to incorporate the
“Diagnosis and Management of the Spondyloarthropathies (SpA)-Impact of Treat to
Target Guidelines” CME educational activity into clinical practice.
1Identify patients with chronic low back pain who are at risk for SpA.
2Use current ASAS diagnostic criteria to make a correct definite diagnosis of
SpA.
3Explain the rationale of the current SpA management recommendations.
4Implement the appropriate management of their patients accordingly.
5Evaluate strategies for educating patients about SpA and life with the disease.
6Apply these strategies in their clinical practices as applicable to the patient
pool, and improve how they involve patients in the therapeutic decision
making process.
Alan Epstein, MD, FACP, FACR.
Associate Professor of Medicine,
University of Pennsylvania School of Medicine
Philadelphia, PA
accreditation requirements and policies of the Accreditation Council for Continuing
Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to
provide continuing medical education for physicians.
UHS-PEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation
in the activity. This continuing education activity meets the criteria of VCU and the Southern
Association of Colleges and Schools. For each activity 0.1 CEUs will be awarded and recorded with
the University. This program is supported by educational grants from AbbVie, Inc., Amgen, Inc.,
Janssen Biotech, Inc, and UCB, Inc.
““Evaluation and Management of Systemic Lupus
Erythematosus, 2015”
participants with the knowledge base, skills set, and tools needed to incorporate
the “Evaluation and Management of Systemic Lupus Erythematosus, 2015” CME
educational activity into clinical practice.
1Evaluate the importance of the disease burden in SLE, consequences of inadequate
disease control, and consequences of inflammatory burden on patients, their
families, their communities and the healthcare system.
2Describe and discuss the impact of disease activity on patient outcomes, and
the challenges of implementing treat to target concepts as applicable in the
management of this highly pleomorphic disease.
3Apply current concepts of management including approaches to measurement of
organ inflammation and/or involvement and disease activity.
4Collaborate with patients in the implementation of treatment goals.
5Apply the principles of evidence based medicine to optimize SLE patient care.
a) Effectively use currently available tools for assessing disease activity in patients with lupus;Evaluate
the EULAR monitoring guidelines and apply them into the care of their lupus patients.
b) Apply the treatment strategies from the EULAR and ACR guidelines and SLICC in their
clinicalpractices and thereby optimize patient care and functioning.
Michelle Petri, MD, MPH
Professor of Medicine, Johns Hopkins University
School of Medicine
Director, Hopkins Lupus Center
Baltimore, MD
accreditation requirements and policies of the Accreditation Council for Continuing Medical
Education (ACCME) through the joint providership of University Health Services Professional
Education Programs, Inc. (UHS-PEP) of Virginia Commonwealth University Health System and
Miller Professional Group. UHS-PEP is accredited by the ACCME to provide continuing medical
education for physicians.
UHS-PEP designates this live program for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
This continuing education activity meets the criteria of VCU and the Southern Association
of Colleges and Schools. For each activity 0.1 CEUs will be awarded and recorded with the
University.
This program is supported by an educational grant from UCB.
“Utilization of Viscosupplementation in the Treatment of
Knee Osteoarthritis: Identifying Potential Patients”
participants with the knowledge base, skills set, and tools needed to incorporate the
“Utilization of Viscosupplementation in the Treatment of Knee Osteoarthritis: Identifying
Potential Patients” CME educational activity into clinical practice.
1Describe the demographics, impact, etiology and pathophysiology of
osteoarthritis of the knee.
2Implement current guidelines for diagnosis and evaluation of the patient
with osteoarthritis of the knee, including consideration of comorbidities
impacting treatment decisions.
3Utilize appropriately currently available treatment modalities including oral
and local therapeutic options, and non-pharmacologic options.
4Recognize patients who have clinical characteristics indicatingappropriate
utilization of hyaluronan therapy.
John RP Tesser, MD, FACP, FACR
Clinical Lecturer in Internal Medicine,
University of Arizona Health Sciences Center
Midwestern University, Arizona College of Osteopathic Medicine,
Phoenix, Arizona
This This educational activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation Council for Continuing
Health System and Miller Professional Group. UHS-PEP is accredited by the ACCME to
provide continuing medical education for physicians.
UHS-PEP designates this live program for a maximum of 1.0 AMA PRA Category 1
Credits™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
This continuing education activity meets the criteria of VCU and the Southern
Association of Colleges and Schools. For each activity 0.1 CEUs will be awarded and
recorded with the University.
This program is supported by an educational grant from Fidia Inc.
7
Traveling To Destin
Direct flights are now available on Southwest (to Northwest
Florida Beaches International Airport at Panama City [Airport
code: ECP]) from BWI, Houston, Nashville, St Louis and direct
flights on Delta from Atlanta.
The closest airport is Northwest Florida Regional Airport (VPS) at
Fort Walton Beach. Direct flights are available on American from
Dallas, on Continental from Houston, on Delta from Atlanta, and
on US Airways from Charlotte.
Accommodations
Hilton Hotel, Destin, Florida where the meeting is held.
Room rate—Single or Double: $249.00 per night plus applicable
taxes and fees. Book your room directly with the Hilton Hotel.
Call the Hilton directly at (850) 267-9500 or toll-free at 1-800367-1271 and speak with a hotel representative or visit http://
www.sandestinbeachhilton.com. Our SPECIAL GROUP CODE to
give the reservationist is CCR.
8
Any hotel reservation made after April 1, 2015 will be taken on
a space available basis at the PREVAILING RATE. LAST YEAR
OUR ROOM BLOCK WAS FILLED BEFORE THE CUT-OFF
DATE!
Hilton Sandestin Golf Resort & Spa
2014 Certificate of Excellence, TripAdvisor
2014 Best Hotels in the USA, U.S. News & World Report
2014 Top 100 Resorts, Event Supplier Network Meeting Planners
In order to receive the CCR room rate, you must be registered
for the Congress of Clinical Rheumatology.
Other hotel accommodations are available next to the Hilton
with meeting rates available. Rooms from $169! For more
information see: http://www.ccrheumatology.com and click
Accommodations [www.ccrheumatology.com/places-to-stay].
ccr thieves’ market
On Friday, May 1 , CCR will host a
st
Thieves’ Market moderated by Dr.
Accreditation &
credit statement
Goals & Objectives
At the conclusion of this forum, the attendees should be able to:
Alan Epstein, M.D. of the University of
This educational activity has been
1. Identify, evaluate and manage
9. Utilize recent updates to treat pain
Pennsylvania.
planned and implemented in accordance
patients with rheumatologic and
with fibromyalgia.
Cases are being solicited from all
with the accreditation requirements and
immunologic diseases according to the
10. Summarize current concepts of
attendees of CCR. Submissions are
policies of the Accreditation Council for
most up-to-date guidelines and clinical
chronic pain management.
due by April 1st, 2015. Cases are to
Continuing Medical Education (ACCME)
developments.
11. Determine the best strategy to
be presented as “stumpers” in the
through the joint providership of University
2. Outline the new developments in
“Treat to Target” for patients with
Thieves’ Market style. Each presenter
Health Services Professional Education
the diagnosis and treatment of ANCA-
psoriatic arthritis.
is provided up to 10 minutes including
Programs, Inc. (UHS-PEP) of Virginia
associated vasculitis.
12. Recognize and diagnose unusual
discussion. If you would like to present
Commonwealth University Health System
3. Evaluate and employ the most
presentations of uncommon as well as
a case, email Alan Epstein at thieves@
and A&R Educational Group, LLC. UHS-
recent updates in the pathogenesis
common rheumatologic diseases, as
ccrheumatology.com.
PEP is accredited by the ACCME to
and treatment of rheumatoid arthritis,
presented at the Thieves’ Market
Include:
provide continuing medical education for
psoriatic arthritis, and sarcoidosis for
13. Evaluate the ICD-10 coding
1 Your Name
physicians.
best outcomes.
changes that are upcoming for
2 Mailing Address
UHS-PEP designates this live program for
4. Explain how to successfully manage
rheumatologists.
pregnancy in lupus.
14. Recognize rheumatic manifestations
5. Select the best single or combination
of endocrine diseases.
3 Daytime Phone Number
a maximum of 24 AMA PRA Category 1
4 Evening Phone Number
Credits™. Physicians should claim only
5 E-mail Address
the credit commensurate with the extent of
of therapeutic agents to individually
15. Explain the effects of and the new
6 Brief paragraph describing your
their participation in the activity
manage osteoporosis therapy and
development with corticosteroids and
proposed presentation and title.
This continuing education activity meets
evaluate the current development of
their discovery, the associated adverse
7 Presentation in Power Point format
the criteria of VCU and the Southern
new agents and strategies in treatment.
events, and the new developments.
There will be an award for the top case
Association of Colleges and Schools. For
6. Compare and contrast the current
16. Explain the adverse effects of
selected and presented.
each activity 2.4 CEUs will be awarded and
and recently approved therapeutic
agents utilized for rheumatoid arthritis
See www.ccrheumatology.com/thieves
recorded with the University.
agents available for the treatment of
and strategies to prevent infections
pulmonary fibrosis associated with
associated with these agents.
for complete entry criteria. Become a
Part of the 2015 Program.
You must be a registered attendee at CCR to present at the Thieves’ Market.
connective tissue diseases.
7. Evaluate Sjogren syndrome patients
for multi-system involvement and devise
Alan Epstein, M.D.
Associate Professor of Medicine
University of Pennsylvania School of Medicine
a plan to manage their potential needs.
8. Evaluate and discuss the
current information on traditional,
complementary and alternative
medications available for systemic lupus
erythematosus.
9
NYRIF
10
North American Young Rheumatology Investigator Forum
The 9th Annual North American Young Rheumatology Investigator Forum will
be held Wednesday April 29, 2015 at the Hilton Sandestin in Destin, Florida
in conjunction with the 31st Annual Congress of Clinical Rheumatology.
NYRIF’s unique format fosters mentorship and emphasizes interaction
between the registrants and faculty and provides an excellent platform
for clinical and research oriented rheumatology fellows and junior faculty
to have their clinical and basic research efforts reviewed, critiqued and
evaluated by an acclaimed geographically diverse panel of rheumatologists.
The top abstracts will be presented as either an oral or poster presentation
to an international audience. In the afternoon, a roundtable discussion with
rheumatologists established in the paths of research, clinical practice and
the pharmaceutical industry will explore career opportunities, challenges,
and lifestyles in the various fields of rheumatology to assist fellows with their
upcoming career decisions. Travel stipends of $250-$1000 will be awarded
to those candidates whose efforts have been considered by the faculty to
have exceptional promise.
NYRIF is designed to be stimulating, interactive and constructive whereby
attendees are able to exchange ideas in an informal, mentoring environment
and develop invaluable networks with the faculty and peers to facilitate
future career contacts. All fellows and junior staff from the U.S. and Canada
within the field of rheumatology are welcome to attend NYRIF and are
invited to stay for the 31st Annual Congress of Clinical Rheumatology that
will immediately follow NYRIF. The CCR registration fee will be waived for
all accepted abstract registrants.
Faculty Judging Panel
The esteemed international judging panel this year includes Dr. Frank
Buttergereit, Charité-University Medicine Berlin, Germany; Dr. Laura Coates,
University of Leeds, England; Susan Manzi, Temple University and Philip
Seo of Johns Hopkins. Dr. Iain McInnes, University of Glasgow, Scotland
will again will be presiding as the lead judge and moderator.
Submission Guidelines
Rheumatology fellows and junior faculty from the U.S. and Canada are
invited to submit abstracts of their original basic or clinical research findings.
The ten most exceptional abstracts will be chosen by the judging panel
for oral presentations and receive a travel stipend of $1000 each. The
next fifteen deemed to be highly meritorious will be asked to present in a
poster session and will receive $500 for travel and meeting expenses. Five
remaining abstracts will be chosen to receive a travel/meeting stipend of
$250. Notification of abstract acceptance for oral or poster presentation as
well as category of travel stipend award will be made by email by April 12,
2015. All judges’ decisions are final.
Abstract submission deadline is March 25, 2015.
For further information on NYRIF, full submission guidelines, or to submit an
abstract, please visit: http://www.nyrif.com
Accreditation
This activity has been approved for AMA PRA Category 1 CreditsTM.
Accommodations
The Hilton Sandestin is offering a limited number of rooms April 28 - 30,
2015 for fellows attending NYRIF at special discounted rate of $199/night.
For further questions, please contact pmclain@bham.net.
Call for Abstracts!
registration form
Mail or Fax form to Congress of Clinical Rheumatology
FAX#: (205) 991-9911
A&R Educational Group, LLC, 6225 Cahaba Valley Road, Birmingham, AL 35242
Name
Specialty
Phone
NPI
Address
City
State
Zip Code
Email Address
Payment Method □ Credit Card □ Check □ Money Order
Credit Card □ VISA □ Mastercard □ American Express
Name on Card
Card Number
Card Billing Zip Code
CVV
□ Discover
Expiration Date
Total From Below
11
Signiture
Registration Fees
CCR Physician Registration Fee
CCR Physician Day Registration
Specify Day(s)_______________
CCR AHP Registration Fee
CCR AHP Day Registration
Specify Day(s)_______________
Retired Physician
Physician In Training: This registration is for Residents and Fellows
ONLY. A written letter from your Program Director is required.*
Banquet Saturday Night (Circle One: Surf and Turf/Vegetarian, max
2 per registrant, 1 hr of CME, Must be registered to Attend)
Banquet Saturday Night Spouse/Guest
(Circle One: Surf and Turf/Vegetarian)
Before 4/12/15
$450
$185/day
On/After
4/12/15
$525
$185/day
$400
$150/day
$475
$150/day
$250
$200*
$300
$225
□ Attending
included in
registration fee
□ Attending
included in
registration fee
Total Fees (include in total above)
“Truly the best clinical rheum meeting of the year.”
Allan Morton, D.O., Detroit, MI
□ Not
Attending
□ Not
Attending
There will be a $25 surcharge for registrations received on site.
Refund policy: An administrative fee of $50 will be charged prior to
4/10/15 and $100 thereafter; no refunds will be issued after April
29, 2015.
Cancellation Policy: A&R Educational Group, LLC reserves the right
to cancel this conference due to insufficient enrollment or unforeseen circumstances.
* Registration fee waived if attending NYRIF with abstract submitted.
NYRIF
National Young Rheumatology
Investigator Forum
Dr. Iain McInnes will chair
the sessions with other
panel members Drs. Frank
Buttgereit, Laura Coates,
Susan Manzi, and Phillip
Seo .
Submit abstracts at:
http://nyrif.com
Congress of Clinical Rheumatology• April 30- may 3, 2015
Sandestin hilton and conference center • Destin FL.

Congress of Clinical Rheumatology April 30

Transcription

Similar documents

15th Annual Rheumatic Disease Conference

Brochure/Registration for Mail/Fax

UC IRVINE DEPARTMENT OF MEDICINE CONFERENCE SCHEDULE BLOCK 7 INTERNS 11/10/14-11/30/14 RESIDENTS 11/11/14-12/1/14

14th Annual Rheumatic Disease Conference

Presenters: Laura Muttini, Founder and Principal, Educational

Rheumatology at Leeds Teaching Hospitals NHS Trust

Indian Rheumatology Association

Bulgarian Accreditation Services CERTIFICATE OF ACCREDITATION

Pulmonary hypertension in inflammatory rheumatic diseases

ISO Certificate of Environment Management System NORPACK